Compare HCA Health Inc (HCA) vs Noble Corporation plc (NE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Noble Corporation plc — how do they compare? HCA Health Inc trades at $443.69 (market cap $95.08B), while Noble Corporation plc trades at $42.28 (market cap $6.54B). The key difference: HCA Health Inc is far larger — about 14.5× Noble Corporation plc's market cap, and Noble Corporation plc pays the higher dividend (4.88%). Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Noble Corporation plc for 26 Days on average.
| HCA | NE | |
|---|---|---|
Market Cap | $95.08B | $6.54B |
Volume | 998,787 | 1,192,391 |
Sector | Health | Energy |
52-Week High | $545.13 | $54.37 |
52-Week Low | $361.32 | $26.70 |
Typical Hold Time | 76 Days | 26 Days |
Enterprise Value | $145.62B | $7.97B |
Dividend Yield | 0.71% | 4.88% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare (HCA) trades at $445.01, up 2.96% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $75.6B in 2025, with net income of $6.78B, and the stock trades at a P/E of 14.73. Analyst consensus is a Buy with a $461.12 price target, though ongoing legal investigations pose a headwind.
The outlook remains positive given solid demand and cost controls, but risks include payer-mix pressure and high debt levels. Upside potential exists if earnings growth continues, but investors should monitor legal developments and interest rate impacts on the leveraged balance sheet.
Noble Corporation (NE) trades at $40.97, down 1.16% on the day, with a bearish technical signal driven by moving averages and ADX indicators. The stock's valuation shows a P/E of 43.59 and P/S of 2.14, while recent earnings have been mixed with two misses and one beat in the last three quarters. A long-term drilling contract in Ghana provides operational stability, but investor sentiment is tempered by an ongoing legal investigation noted in recent news.
The outlook for NE is cautious; analyst consensus is a Buy with a $52 price target, implying potential upside, but risks include earnings volatility and legal scrutiny. Positive cash flow and a dividend payment support income investors, yet the bearish technical trend and declining revenue in 2026 warrant close monitoring for any fundamental deterioration.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Noble Corporation plc
Noble Corporation plc is a leading offshore drilling contractor for the oil and gas industry. The company owns and operates a high-specification fleet of mobile offshore drilling units, including drillships and semi-submersibles, that are used for exploration and production activities in deepwater and harsh environments worldwide. Noble focuses on providing safe, efficient, and reliable drilling services to major and independent oil and gas companies globally.
Read more on NE →
